Florida, December 20, 2017: The Global Preimplantation Genetic Testing Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

    The Global Preimplantation Genetic Testing Market is expected to exceed more than US$ 546.37 Million by 2022 at a CAGR of 10% in the given forecast period.

    The Global Preimplantation Genetic Testing Market is segmented on the lines of its technology, product & service, procedure type, application, end user and regional. Based on technology segmentation it covers next generation sequencing (NGS), polymerase chain reaction (PCR), fluorescent in-situ hybridization (FISH), comparative genomic hybridization (CGH), single nucleotide polymorphism (SNP). Based on product & service segmentation it covers reagents & consumables, instruments, software & services.

    This report provides:

    1) An overview of the global market for Global Preimplantation Genetic Testing Market and related technologies.
    2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
    3) Identifications of new market opportunities and targeted promotional plans for Preimplantation Genetic Testing Market.
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

     Browser Full Report @: https://www.marketresearchengine.com/preimplantation-genetic-testing-market

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), CooperSurgical, Inc. (U.S.), and Beijing Genomics Institute (BGI) (China) Company profile includes assign such as company summary, financial summary,

    The scope of the report includes a detailed study of global and regional markets on Global Preimplantation Genetic Testing Market with the reasons given for variations in the growth of the industry in certain regions.

    The major driving factors of Global Preimplantation Genetic Testing Market are as follows:

    • Decreasing fertility rates worldwide
    • Growing public-private savings in the field of preimplantation genetic testing
    • Increasing number of fertility clinics worldwide
    • New development technological advancements in the field of genetic analysis
    • Highly threat of chromosomal abnormalities with advancing maternal age

    The restraining factors of Global Preimplantation Genetic Testing Market are as follows:

    • Adverse government regulations
    • Expensive practical associated with preimplantation genetic testing
    • Procedural drawbacks of Preimplantation Genetic Testing With Advancing Age
    • Socio ethical interests Regarding Preimplantation Genetic examination

    Request Sample Report: https://www.marketresearchengine.com/preimplantation-genetic-testing-market 

    Developing knowledge about genetic systems for identification of chromosomal variations from the norm and fetus screening for effective IVF holds development prospects for this vertical over the estimate time frame. Early discovery of the chromosomal maladies, which holds potential for lowering the quantity of individuals experiencing intrinsic ailments, PGD can be performed for screening of a scope of restorative conditions, for example, Down’s syndrome, inheritable illnesses and qualities of other physiological anomaly. Expanding tolerant awareness about PGD system and rising predominance of hereditary issue among newborn children has prompted the ascent sought after for PGD alongside IVF methodology. The mix of PGD and IVF has enhanced the rate of fruitful pregnancy because of decreased odds of passing the undesired hereditary material in the developing life. Thus decreases the quantity of offspring’s conceived with acquired chromosomal variations from the norm. This can be credited to the expanded interest for Preimplantation genetic testing (PGT) administrations.

    Based on procedure type segmentation it covers preimplantation genetic screening, preimplantation genetic diagnosis. Based on application segmentation it covers aneuploidy, structural chromosomal abnormalities, and single gene disorders, x-linked disorders, hla typing, gender identification. Based on end user segmentation it covers maternity centers & fertility clinics, hospitals, diagnostic labs, and service providers, research laboratories & academic institutes.

    Table of Contents

    1 Introduction

    1.1    KEY TAKE AWAYS
    1.2    REPORT DESCRIPTION
    1.3    MARKETS COVERED
    1.4    STAKEHOLDERS
    1.5    RESEARCH METHODOLOGY
    1.5.1    MARKET SIZE
    1.5.2    MARKET SHARE
    1.5.3    KEY DATA POINTS FROM SECONDARY SOURCES
    1.5.4    KEY DATA POINTS FROM PRIMARY SOURCES

    2 Research Methodology

    2.1 Research Methodology Steps
    2.1.1 Secondary Research
    2.1.1.1 Key Data From Secondary Sources
    2.1.2 Primary Research
    2.1.2.1 Breakdown of Primaries
    2.1.2.2 Key Data From Primary Sources
    2.2 Market Size Estimation
    2.2.1 Research Methodology: Bottom-Up Approach
    2.2.2 Research Methodology: Top-Down Approach
    2.3 Research Design
    2.4 Data Validation and Triangulation
    2.4.1 Assumptions for the Study

    3 Executive Summary

    4 Premium Insights

    5 Preimplantation Genetic Testing Market: Overview

    6 Industry Insights

    7 Preimplantation Genetic Diagnosis and Screening Market, By Procedure Type

    8 Preimplantation Genetic Diagnosis and Screening Market, By Technology

    9 Preimplantation Genetic Diagnosis and Screening Market, By Product and Service

    10 Preimplantation Genetic Diagnosis and Screening Market, By Application

    11 Preimplantation Genetic Diagnosis and Screening Market, By End User

    12 Preimplantation Genetic Diagnosis and Screening Market, By Region

    13 Preimplantation Genetic Testing Market: Competitive Landscape

    14 Company Profiles

    14.1 Top Product Manufacturers

    14.1.1 Illumina, Inc.

    14.1.2 Thermo Fisher Scientific Inc.

    14.1.3 Agilent Technologies, Inc.

    14.1.4 Perkinelmer, Inc.

    14.1.5 Coopersurgical, Inc. (A Subsidiary of the Cooper Companies, Inc.)

    14.1.6 ABBott Laboratories

    14.1.7 Natera, Inc.

    14.1.8 Rubicon Genomics (A Subsidiary of Takara Bio Usa Holdings, Inc.)

    14.1.9 Oxford Gene Technology

    14.1.10 Yikon Genomics

    14.1.11 Scigene

    14.2 Top Service Provider Companies

    14.2.1 Beijing Genomics Institute

    14.2.2 Good Start Genetics, Inc.

    14.2.3 Invicta Genetics

    14.2.4 Combimatrix Corporation

    14.2.5 Genea Limited

    14.2.6 Progenesis

    Media Contact

    Contact Person: John Bay

    Email: john@marketresearchengine.com

    Phone: +1-855-984-1862

    Country: United States

    Website: https://www.marketresearchengine.com

     

    Source: http://www.financeswire.com/preimplantation-genetic-testing-market-to-exceed-us-546-million-by-2022